Table 3.
Relation of medical treatment to M/E at last M/E measurement
| M/E | |||
|---|---|---|---|
| Not treated | Treated | ||
| Number | 137 | ||
| eGFR | 13.4 ± 5.1 | ||
| Antithrombotic | 57 (41.6) | 1.04 ± 0.39 | 1.05 ± 0.39 |
| ACE inhibitor | 21 (15.3) | 1.01 ± 0.36 | 1.21 ± 0.50a |
| Angiotensin 2 antagonist | 24 (17.5) | 1.04 ± 0.41 | 1.04 ± 0.32 |
| β-blocker | 84 (61.3) | 0.99 ± 0.35 | 1.07 ± 0.41 |
| Calcium antagonist | 55 (40.1) | 0.99 ± 0.37 | 1.11 ± 0.42 |
| Any antihypertensive | 118 (86.1) | 0.85 ± 0.32 | 1.07 ± 0.39a |
| Diuretics | 95 (69.3) | 0.93 ± 0.35 | 1.09 ± 0.40a |
| Sodium bicarbonate | 53 (38.7) | 1.03 ± 0.36 | 1.06 ± 0.44 |
| ESA | 51 (37.2) | 1.04 ± 0.40 | 1.04 ± 0.38 |
| Active vitamin D | 51 (37.2 | 1.00 ± 0.35 | 1.10 ± 0.45 |
a: p < 0.05. ACE: angiotensin converting enzyme; ESA: erythropoiesis stimulating agent